JPS56103110A - Sustained release medicinal composition - Google Patents

Sustained release medicinal composition

Info

Publication number
JPS56103110A
JPS56103110A JP157881A JP157881A JPS56103110A JP S56103110 A JPS56103110 A JP S56103110A JP 157881 A JP157881 A JP 157881A JP 157881 A JP157881 A JP 157881A JP S56103110 A JPS56103110 A JP S56103110A
Authority
JP
Japan
Prior art keywords
sustained release
medicinal composition
release medicinal
composition
sustained
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP157881A
Other languages
English (en)
Japanese (ja)
Inventor
Maikuru Dan Jieemusu
Furanshisu Ramupaado Jiyon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boots Co PLC
Original Assignee
Boots Co PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/194,453 external-priority patent/US4308251A/en
Application filed by Boots Co PLC filed Critical Boots Co PLC
Publication of JPS56103110A publication Critical patent/JPS56103110A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP157881A 1980-01-11 1981-01-08 Sustained release medicinal composition Pending JPS56103110A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11143080A 1980-01-11 1980-01-11
US06/194,453 US4308251A (en) 1980-01-11 1980-10-17 Controlled release formulations of orally-active medicaments

Publications (1)

Publication Number Publication Date
JPS56103110A true JPS56103110A (en) 1981-08-18

Family

ID=26808896

Family Applications (1)

Application Number Title Priority Date Filing Date
JP157881A Pending JPS56103110A (en) 1980-01-11 1981-01-08 Sustained release medicinal composition

Country Status (22)

Country Link
JP (1) JPS56103110A (es)
AT (1) AT374681B (es)
AU (1) AU542824B2 (es)
BE (1) BE886998A (es)
CA (1) CA1140466A (es)
CH (1) CH646604A5 (es)
DE (1) DE3100191A1 (es)
DK (1) DK6181A (es)
ES (2) ES8205353A1 (es)
FI (1) FI76927C (es)
FR (1) FR2473308B1 (es)
GB (1) GB2067072B (es)
GR (1) GR73843B (es)
IE (1) IE50806B1 (es)
IN (1) IN151913B (es)
IT (1) IT1221041B (es)
LU (1) LU83052A1 (es)
NL (1) NL8100037A (es)
NO (1) NO156153C (es)
NZ (1) NZ195933A (es)
SE (1) SE447450B (es)
ZA (1) ZA81136B (es)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59227817A (ja) * 1983-06-07 1984-12-21 Toyo Jozo Co Ltd 持続性経口用ブレデニン製剤
JPS6072813A (ja) * 1983-06-14 1985-04-24 シンテックス・ファーマシユーテイカルズ・インターナシヨナル・リミテツド 制御放出性ナプロキセンおよびナプロキセンナトリウム錠

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2496082A (en) * 1947-05-24 1950-01-31 Ashenfelter William Scaffold structure
IT1144911B (it) * 1981-03-19 1986-10-29 Pharmatec Spa Composizione farmaceutica a rilascio controllato contenente ibuprofen
ZA836031B (en) * 1983-08-16 1985-02-27 Verex Lab Constant release rate solid dosage theophylline formulation
ZA836030B (en) * 1983-08-16 1985-02-27 Verex Lab Constant order release solid dosage indomethacin formulation and method of treating arthritis and other inflammatory conditions
US5385738A (en) * 1983-10-14 1995-01-31 Sumitomo Pharmaceuticals Company, Ltd. Sustained-release injection
US4855134A (en) * 1983-10-14 1989-08-08 Sumitomo Pharmaceuticals Company, Limited Sustained-release preparation
EP0138216B1 (en) * 1983-10-14 1993-01-07 Sumitomo Pharmaceuticals Company, Limited Sustained-release ifn preparation for parenteral administration
US4774091A (en) * 1983-10-14 1988-09-27 Sumitomo Pharmaceuticals Company, Ltd. Long-term sustained-release preparation
DE3688188T2 (de) * 1985-12-27 1993-10-14 Koken Kk Verfahren zur Herstellung einer Formulierung mit verzögerter Freisetzung.
GB8601204D0 (en) * 1986-01-18 1986-02-19 Boots Co Plc Therapeutic agents
ZA881301B (en) * 1987-02-27 1989-10-25 Lilly Co Eli Sustained release matrix formulations
US4968508A (en) * 1987-02-27 1990-11-06 Eli Lilly And Company Sustained release matrix
WO1997002019A1 (en) * 1995-06-30 1997-01-23 Baylor University Polyester/carboxylic acid composite materials

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5191314A (es) * 1975-01-06 1976-08-10

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2953497A (en) * 1953-06-03 1960-09-20 Howard A Press Therapeutic tablets
BE604564A (es) * 1960-06-06
US3577514A (en) * 1968-06-10 1971-05-04 Pfizer Sustained release pharmaceutical tablets
US3773920A (en) * 1971-07-14 1973-11-20 Nikken Chemicals Co Ltd Sustained release medicinal composition
US3906086A (en) * 1971-07-19 1975-09-16 Richard G Powers Timed-release aspirin
JPS5411226A (en) * 1977-06-24 1979-01-27 Shin Etsu Chem Co Ltd Disintegratable granule

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5191314A (es) * 1975-01-06 1976-08-10

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59227817A (ja) * 1983-06-07 1984-12-21 Toyo Jozo Co Ltd 持続性経口用ブレデニン製剤
JPH0530810B2 (es) * 1983-06-07 1993-05-11 Asahi Chemical Ind
JPS6072813A (ja) * 1983-06-14 1985-04-24 シンテックス・ファーマシユーテイカルズ・インターナシヨナル・リミテツド 制御放出性ナプロキセンおよびナプロキセンナトリウム錠

Also Published As

Publication number Publication date
ES498369A0 (es) 1982-06-01
BE886998A (fr) 1981-07-08
FI810056L (fi) 1981-07-12
GR73843B (es) 1984-05-07
SE8100104L (sv) 1981-07-12
FR2473308A1 (fr) 1981-07-17
FI76927C (fi) 1989-01-10
IT8147537A0 (it) 1981-01-09
FI76927B (fi) 1988-09-30
GB2067072A (en) 1981-07-22
ATA5481A (de) 1983-10-15
AT374681B (de) 1984-05-25
DE3100191C2 (es) 1988-09-01
NO156153B (no) 1987-04-27
GB2067072B (en) 1983-08-10
NL8100037A (nl) 1981-08-03
FR2473308B1 (fr) 1985-07-19
NO810062L (no) 1981-07-13
ZA81136B (en) 1982-01-27
DK6181A (da) 1981-07-12
SE447450B (sv) 1986-11-17
AU6597681A (en) 1981-07-16
NZ195933A (en) 1982-11-23
ES509179A0 (es) 1982-12-16
IE50806B1 (en) 1986-07-23
LU83052A1 (fr) 1982-09-10
NO156153C (no) 1987-08-05
IE810036L (en) 1981-07-11
AU542824B2 (en) 1985-03-14
IN151913B (es) 1983-09-03
ES8205353A1 (es) 1982-06-01
IT1221041B (it) 1990-06-21
DE3100191A1 (de) 1981-12-10
CA1140466A (en) 1983-02-01
CH646604A5 (fr) 1984-12-14
ES8301629A1 (es) 1982-12-16

Similar Documents

Publication Publication Date Title
GB2053681B (en) Sustained release pharmaceutical composition
GB2067073B (en) Dipyridamole sustained release formulations
GB2108841B (en) Sustained release layered pharmaceutical compositions
GB2061950B (en) Sustained release therapeutic compositions
GB2077587B (en) Controlled release potassium dosage form
GB8307960D0 (en) Sustained release therapeutic compositions
ZA813465B (en) Pharmaceutical composition
GB2053682B (en) Sustained release pharmaceutical compositions
GB2068730B (en) Oral composition
JPS5770813A (en) Dental composition
JPS56103110A (en) Sustained release medicinal composition
JPS56169609A (en) Dental composition
GB2098867B (en) Sustained release pharmaceutical composition
JPS57134411A (en) Oral composition
JPS57149230A (en) Medicinal composition
GB2072504B (en) Pharmaceutical compositions
GB2092000B (en) Oral composition
ZA815700B (en) Pharmaceutical compositions
GB2074028B (en) Pharmaceutical formulations
GB2090137B (en) Oral composition
JPS56121560A (en) Slowly releasing perfume composition
JPS57206615A (en) Medicinal composition containing guanfasin
EP0051789A3 (en) Therapeutic composition
DE3176849D1 (en) Pharmaceutical composition comprising 4-carbamoyl-imidazolium-5-olate
DE3278126D1 (en) Sustained release compositions